Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-016623
Filing Date
2017-06-16
Accepted
2017-06-16 20:00:27
Documents
1
Period of Report
2017-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4031
  Complete submission text file 0000899243-17-016623.txt   5333
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Issuer) CIK: 0001285819 (see all company filings)

EIN.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address
Demopulos Peter A MD (Reporting) CIK: 0001472161 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34475 | Film No.: 17917242